These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 3282216)
1. A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge. Doyle WJ; McBride TP; Skoner DP; Maddern BR; Gwaltney JM; Uhrin M Pediatr Infect Dis J; 1988 Mar; 7(3):229-38. PubMed ID: 3282216 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of an anticholinergic-sympathomimetic combination in induced rhinovirus colds. Doyle WJ; Riker DK; McBride TP; Hayden FG; Hendley JO; Swarts JD; Gwaltney JM Ann Otol Rhinol Laryngol; 1993 Jul; 102(7):521-7. PubMed ID: 8392820 [TBL] [Abstract][Full Text] [Related]
3. Effect of intranasal challenge with interleukin-6 on upper airway symptomatology and physiology in allergic and nonallergic patients. Gentile DA; Yokitis J; Angelini BL; Doyle WJ; Skoner DP Ann Allergy Asthma Immunol; 2001 May; 86(5):531-6. PubMed ID: 11379804 [TBL] [Abstract][Full Text] [Related]
4. Combined antiviral-antimediator treatment for the common cold. Gwaltney JM; Winther B; Patrie JT; Hendley JO J Infect Dis; 2002 Jul; 186(2):147-54. PubMed ID: 12134249 [TBL] [Abstract][Full Text] [Related]
5. Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection. McBride TP; Doyle WJ; Hayden FG; Gwaltney JM Arch Otolaryngol Head Neck Surg; 1989 Sep; 115(9):1054-9. PubMed ID: 2548538 [TBL] [Abstract][Full Text] [Related]
6. The effect of an oral combined preparation (antihistamine and decongestant) on Eustachian tube function in the common cold. Virtanen H ORL J Otorhinolaryngol Relat Spec; 1982; 44(5):268-76. PubMed ID: 6182516 [TBL] [Abstract][Full Text] [Related]
7. Effect of exogenous surfactant on ventilatory and clearance function of the rat's eustachian tube. van Heerbeek N; Tonnaer EL; Ingels KJ; Curfs JH; Cremers CW Otol Neurotol; 2003 Jan; 24(1):6-10. PubMed ID: 12544020 [TBL] [Abstract][Full Text] [Related]
8. Nasal and otologic effects of experimental influenza A virus infection. Doyle WJ; Skoner DP; Hayden F; Buchman CA; Seroky JT; Fireman P Ann Otol Rhinol Laryngol; 1994 Jan; 103(1):59-69. PubMed ID: 8291861 [TBL] [Abstract][Full Text] [Related]
9. Rhinovirus 39 infection in allergic and nonallergic subjects. Doyle WJ; Skoner DP; Fireman P; Seroky JT; Green I; Ruben F; Kardatzke DR; Gwaltney JM J Allergy Clin Immunol; 1992 May; 89(5):968-78. PubMed ID: 1316390 [TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. Gwaltney JM; Park J; Paul RA; Edelman DA; O'Connor RR; Turner RB Clin Infect Dis; 1996 Apr; 22(4):656-62. PubMed ID: 8729205 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Eccles R; Jawad MS; Jawad SS; Angello JT; Druce HM Am J Rhinol; 2005; 19(1):25-31. PubMed ID: 15794071 [TBL] [Abstract][Full Text] [Related]
13. Effect of terfenadine on nasal, eustachian tube, and pulmonary function after provocative intranasal histamine challenge. Skoner DP; Doyle WJ; Boehm S; Fireman P Ann Allergy; 1991 Dec; 67(6):619-24. PubMed ID: 1750727 [TBL] [Abstract][Full Text] [Related]
14. Time-to-onset of cold and flu symptom relief: A randomized, double-blind, placebo-controlled pilot study for a multi-symptom combination product. Zhang Y; Mallefet P Int J Clin Pharmacol Ther; 2018 Dec; 56(12):604-611. PubMed ID: 30220290 [TBL] [Abstract][Full Text] [Related]
15. Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, double-blind, controlled trial. Abisheganaden JA; Avila PC; Kishiyama JL; Liu J; Yagi S; Schnurr D; Boushey HA Am J Med; 2000 Apr; 108(6):453-9. PubMed ID: 10781777 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366 [TBL] [Abstract][Full Text] [Related]
17. Prechallenge antibodies: moderators of infection rate, signs, and symptoms in adults experimentally challenged with rhinovirus type 39. Alper CM; Doyle WJ; Skoner DP; Buchman CA; Seroky JT; Gwaltney JM; Cohen SA Laryngoscope; 1996 Oct; 106(10):1298-305. PubMed ID: 8849805 [TBL] [Abstract][Full Text] [Related]